Perennial Investment Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$239K Sell
6,508
-383
-6% -$18.1K 0.02% 446
2025
Q4
$351K Buy
6,891
+3,082
+81% +$158K 0.03% 345
2025
Q3
$211K Sell
3,809
-746
-16% -$43.7K 0.02% 456
2025
Q2
$314K Sell
4,555
-118
-3% -$8.03K 0.03% 340
2025
Q1
$325K Buy
+4,673
New +$386K 0.04% 309

Other funds holding NVO

Perennial Investment Advisors's NVO Position: Q1 2026 in Review

Perennial Investment Advisors reduced its Novo Nordisk (NVO) stake by 5.6% in Q1 2026, selling an estimated $18.1K and leaving 6,508 shares worth $239K. The position accounts for 0.02% of the portfolio, ranked #446.

Perennial Investment Advisors first reported a position in NVO in Q1 2025 and has held it in 5 quarters since. The position peaked at $351K in Q4 2025. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Perennial Investment Advisors held 6,508 shares of Novo Nordisk worth $239K as of Q1 2026.
  • Perennial Investment Advisors sold 383 Novo Nordisk shares in Q1 2026, an estimated $18.1K.
  • Novo Nordisk made up 0.02% of Perennial Investment Advisors's portfolio in Q1 2026, its #446 holding.
  • Perennial Investment Advisors first reported a position in Novo Nordisk in Q1 2025 and has held it in 5 quarters since.
  • Perennial Investment Advisors's Novo Nordisk position peaked at $351K in Q4 2025.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Perennial Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.